Vaccine to prevent C. difficile infection in adults 65 and older
Part of Immune system & allergy, Infections clinical trials.
This study tests a vaccine that may help protect against a serious gut infection called C. difficile, which often happens after antibiotics or hospital stays. If you are 65 or older and have certain health conditions or recent antibiotic use, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years of age or older.
- You have had recent contact with a hospital or clinic, or you have taken antibiotics recently, or you have a chronic medical condition.
- You have never had a C. difficile infection before.
- You have not had surgery to remove part of your small or large intestine.
- You do not have frequent diarrhea (three or more loose stools a day, more than once a month).
- You have not already received a C. difficile vaccine or antibody treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking vancomycin by mouth can prevent another C. diff infection when you need to take other antibiotics. It’s for patients who recently had C. diff and are about to start a new antibiotic course.
This trial tests a new medicine called VE303, a live bacterial therapy, to prevent C. diff infections from coming back. It is for people who have had C. diff at least once in the last 6 months, or who are at high risk for a repeat infection due to age or other health problems.
This trial studies how Clostridioides difficile (C. diff) affects healthy people by intentionally giving a controlled dose. The goal is to understand the infection better and help develop future treatments or vaccines.
This study tests a new antibody (AZD5148) to prevent C. diff infection from coming back. If you have a current C. diff infection and are being treated with antibiotics, you may be able to join.
This trial tests whether giving vancomycin through a tube into the stomach can prevent a serious gut infection called C. diff in people who are very sick in the ICU and taking antibiotics. If you qualify, you might receive this medicine to lower your risk.
This study tests whether taking a capsule form of fecal microbiota transplant (FMT) can help adults with their first C. difficile infection—or a first relapse—get better and reduce repeat episodes. Participants also take specific antibiotics for C. difficile as part of the study process.
Hear when a new Clostridoides Difficile Associated Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.